AttilaKovacsMD
Cardiology • Saint Louis, MOEchocardiography
Professor, Cardiovascular Division, Washington University School of Medicine
Dr. Kovacs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1020 N Mason Rd
Ste 100
Saint Louis, MO 63141Phone+1 314-362-1291Fax+1 314-362-4278
Education & Training
University of Missouri-ColumbiaFellowship, Cardiovascular Disease, 1991 - 1994
New York Medical College (Metropolitan)Residency, Internal Medicine, 1987 - 1991
Semmelweis UniversityClass of 1985
Certifications & Licensure
MO State Medical License 1994 - 2025
NY State Medical License 1990 - 1992- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease Start of enrollment: 2016 Jun 06
- PRediction of Early PostoperAtive Right vEntricular Failure in Mitral Valve Replacement/Repair Patients Start of enrollment: 2016 Oct 01
Publications & Presentations
PubMed
- Hypoxia sensing in resident cardiac macrophages regulates monocyte fate specification following ischemic heart injury.Farid F Kadyrov, Andrew L Koenig, Junedh M Amrute, Hao Dun, Wenjun Li
Nature Cardiovascular Research. 2024-11-01 - Safety Evaluations of Rapamycin Perfluorocarbon Nanoparticles in Ovarian Tumor-Bearing Mice.Qingyu Zhou, John C Harding, Ping Fan, Ivan Spasojevic, Attila Kovacs
Nanomaterials. 2024-10-31 - 1 citationsInfiltrating monocytes drive cardiac dysfunction in a cardiomyocyte-restricted mouse model of SARS-CoV-2 infection.Oleksandr Dmytrenko, Shibali Das, Attila Kovacs, Markus Cicka, Meizi Liu
Journal of Virology. 2024-09-17
Press Mentions
Efficacy and Tolerability of Bevacizumab in Patients with Severe Covid-19February 5th, 2021
Nutritional Modulation of Heart Failure in Mitochondrial Pyruvate Carrier–Deficient MiceOctober 26th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
